Research output per year
Research output per year
- 13 results
Search results
-
2022
The Omnipresence of DYRK1A in Human Diseases
Deboever, E., Fistrovich, A., Hulme, C. & Dunckley, T., Aug 2022, In: International journal of molecular sciences. 23, 16, 9355.Research output: Contribution to journal › Review article › peer-review
Open Access14 Scopus citations -
2021
Systems modeling of metabolic dysregulation in neurodegenerative diseases
Baloni, P., Funk, C. C., Readhead, B. & Price, N. D., Oct 2021, In: Current Opinion in Pharmacology. 60, p. 59-65 7 p.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
The viral hypothesis: how herpesviruses may contribute to Alzheimer’s disease
Wainberg, M., Luquez, T., Koelle, D. M., Readhead, B., Johnston, C., Darvas, M. & Funk, C. C., Oct 2021, In: Molecular Psychiatry. 26, 10, p. 5476-5480 5 p.Research output: Contribution to journal › Review article › peer-review
Open Access17 Scopus citations -
2020
Do infections have a role in the pathogenesis of Alzheimer disease?
Itzhaki, R. F., Golde, T. E., Heneka, M. T. & Readhead, B., Apr 1 2020, In: Nature Reviews Neurology. 16, 4, p. 193-197 5 p.Research output: Contribution to journal › Review article › peer-review
89 Scopus citations -
2017
Targeting tumor necrosis factor alpha for Alzheimer’s disease
DeCourt, B., Lahiri, D. K. & Sabbagh, M. N., Apr 1 2017, In: Current Alzheimer research. 14, 4, p. 412-425 14 p.Research output: Contribution to journal › Review article › peer-review
255 Scopus citations -
2015
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
Talboom, J. S., Velazquez, R. & Oddo, S., 2015, In: npj Aging and Mechanisms of Disease. 1, 1, 15008.Research output: Contribution to journal › Review article › peer-review
Open Access54 Scopus citations -
2013
Autophagic/lysosomal dysfunction in Alzheimer's disease
Orr, M. E. & Oddo, S., 2013, In: Alzheimer's Research and Therapy. 5, 5, 53.Research output: Contribution to journal › Review article › peer-review
Open Access140 Scopus citations -
2012
Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: A new avenue for a disease modifying treatment of Alzheimers?
Smith, B., Medda, F., Gokhale, V., Dunckley, T. & Hulme, C., Nov 21 2012, In: ACS chemical neuroscience. 3, 11, p. 857-872 16 p.Research output: Contribution to journal › Review article › peer-review
120 Scopus citations -
2008
Genomic and proteomic biomarker discovery in neurological disease
Robeson, R. L. H., Siegel, A. M. & Dunckley, T., 2008, In: Biomarker Insights. 2008, 3, p. 73-86 14 p.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations -
2007
A generic research paradigm for identification and validation of early molecular diagnostics and new therapeutics in common disorders
Coon, K. D., Dunckley, T. L. & Stephan, D. A., 2007, In: Molecular Diagnosis and Therapy. 11, 1, p. 1-14 14 p.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
2006
Genetics, transcriptomics, and proteomics of Alzheimer's disease
Papassotiropoulos, A., Fountoulakis, M., Dunckley, T., Stephan, D. A. & Reiman, E. M., Apr 2006, In: Journal of Clinical Psychiatry. 67, 4, p. 652-670 19 p.Research output: Contribution to journal › Review article › peer-review
79 Scopus citations -
2005
Discovery and development of biomarkers of neurological disease
Dunckley, T., Coon, K. D. & Stephan, D. A., Mar 1 2005, In: Drug discovery today. 10, 5, p. 326-334 9 p.Research output: Contribution to journal › Review article › peer-review
68 Scopus citations -
2004
Biomarker identification in neurologic diseases: Improving diagnostics and therapeutics
Coon, K. D., Dunckley, T. & Stephan, D. A., May 1 2004, In: Expert Review of Molecular Diagnostics. 4, 3, p. 361-375 15 p.Research output: Contribution to journal › Review article › peer-review
7 Scopus citations